Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma. (Q54544469)

31 May 2018

title

Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma. (English)

1 reference

31 May 2018

esophageal squamous cell carcinoma

main subject

1 reference

Dongli Yue

1 reference

31 May 2018

Qingxia Fan

1 reference

31 May 2018

Xinfeng Chen

1 reference

31 May 2018

Feng Li

1 reference

31 May 2018

Liping Wang

1 reference

31 May 2018

Lan Huang

1 reference

31 May 2018

Wenjie Dong

1 reference

31 May 2018

Xiaoqi Chen

1 reference

31 May 2018

Zhen Zhang

1 reference

31 May 2018

Jinyan Liu

1 reference

31 May 2018

Fei Wang

1 reference

31 May 2018

Meng Wang

1 reference

31 May 2018

Bin Zhang

1 reference

31 May 2018

Yi Zhang

1 reference

31 May 2018

language of work or name

English

0 references

publication date

21 November 2013

1 reference

31 May 2018

Experimental Cell Research

published in

1 reference

31 May 2018

volume

322

1 reference

31 May 2018

issue

1 reference

31 May 2018

page(s)

149-158

1 reference

31 May 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

7 January 2021

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Population attributable risks of esophageal and gastric cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Purification and Cloning of Hepatocyte Growth Factor Activator Inhibitor Type 2, a Kunitz-type Serine Protease Inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Characterization of placental bikunin, a novel human serine protease inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Mechanisms of caspase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

p53 protein expression and prognosis in squamous cell carcinoma of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Hepatocyte growth factor: a multifunctional cytokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Cancer epigenomics: DNA methylomes and histone-modification maps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

The hepatocyte growth factor regulatory factors in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

10.1016/J.YEXCR.2013.11.009

7 January 2021

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018